Europe narcolepsy market is anticipated to reach US$ 1,532.5 Mn in 2027 from US$ 671.1Mn in 2018. The Narcolepsy market is expected to rise with a CAGR of 9.7% from 2019-2027.
The narcolepsy market is estimated to grow due to the key driving factors such as growing research and developments and increasing awareness across the region. However, the factor such as challenges related to narcolepsy is likely to act as major restraining factor for the growth of the market.
Narcolepsy is a rare chronic sleep disorder that is caused due to the loss of neurons that produces hypocretin. Various developments have been made to make medicines that can reduce the symptoms of narcolepsy. Several research and developments are being conducted across countries such as Germany, the UK, and other countries in the European region. For instance, in April 2019, in Germany, research and development activities were carried out at Inserm and Université de Montpellier. The research was conducted in collaboration with international teams that helped to conducted studies for epidemiological and clinical research for the drug Solriamfetol among the people living with narcolepsy.
In addition, the study was conducted in collaboration with Jazz Pharmaceuticals, the company has invested in the trial, and it also holds a license to develop and commercialize Solriamfetol. The study was a phase III clinical trial, and the results showed that the drug has no side effects to the patients living with narcolepsy. Thus, owing to growing research and development activities for narcolepsy is likely to enhance the growth of the market during the forecast period.
Europe Narcolepsy – Market Segmentation
Europe Narcolepsy Market – By Type
Europe Market – By Product
Europe Market – By Distribution Channel
By Geography
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 671.1 Million |
| Market Size by 2027 | US$ 1,532.5 Million |
| CAGR (2019 - 2027) | 9.7% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Type
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Narcolepsy Market is valued at US$ 671.1 Million in 2018, it is projected to reach US$ 1,532.5 Million by 2027.
As per our report Europe Narcolepsy Market, the market size is valued at US$ 671.1 Million in 2018, projecting it to reach US$ 1,532.5 Million by 2027. This translates to a CAGR of approximately 9.7% during the forecast period.
The Europe Narcolepsy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Narcolepsy Market report:
The Europe Narcolepsy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Narcolepsy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Narcolepsy Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Narcolepsy Market
